| Literature DB >> 27325740 |
Caitlin Kozel1, Brytteny Thompson2, Samantha Hustak2, Chelsea Moore2, Akio Nakashima3, Chingakham Ranjit Singh2, Megan Reid2, Christian Cox2, Evangelos Papadopoulos4, Rafael E Luna4, Abbey Anderson2, Hideaki Tagami5, Hiroyuki Hiraishi2, Emily Archer Slone2, Ken-Ichi Yoshino3, Masayo Asano2, Sarah Gillaspie2, Jerome Nietfeld6, Jean-Pierre Perchellet2, Stefan Rothenburg2, Hisao Masai7, Gerhard Wagner4, Alexander Beeser2, Ushio Kikkawa3, Sherry D Fleming2, Katsura Asano8.
Abstract
ATF4 is a pro-oncogenic transcription factor whose translation is activated by eIF2 phosphorylation through delayed re-initiation involving two uORFs in the mRNA leader. However, in yeast, the effect of eIF2 phosphorylation can be mimicked by eIF5 overexpression, which turns eIF5 into translational inhibitor, thereby promoting translation of GCN4, the yeast ATF4 equivalent. Furthermore, regulatory protein termed eIF5-mimic protein (5MP) can bind eIF2 and inhibit general translation. Here, we show that 5MP1 overexpression in human cells leads to strong formation of 5MP1:eIF2 complex, nearly comparable to that of eIF5:eIF2 complex produced by eIF5 overexpression. Overexpression of eIF5, 5MP1 and 5MP2, the second human paralog, promotes ATF4 expression in certain types of human cells including fibrosarcoma. 5MP overexpression also induces ATF4 expression in Drosophila The knockdown of 5MP1 in fibrosarcoma attenuates ATF4 expression and its tumor formation on nude mice. Since 5MP2 is overproduced in salivary mucoepidermoid carcinoma, we propose that overexpression of eIF5 and 5MP induces translation of ATF4 and potentially other genes with uORFs in their mRNA leaders through delayed re-initiation, thereby enhancing the survival of normal and cancer cells under stress conditions.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27325740 PMCID: PMC5062967 DOI: 10.1093/nar/gkw559
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971